$KLRS
Kalaris Therapeutics, Inc. Common Stock
XNAS
As of the latest tick, KLRS is trading at $5.37, up 16.49% versus the previous close of $4.61. Our scanner has flagged KLRS 4 times on unusual volume in the last 30 days.
Key Stats
- Price
- $5.37
- Change today
- +16.49%
- Previous close
- $4.61
- 52-week range
- $2.14 – $11.88
- Market cap
- $110M
- Institutional own.
- 79.52%
- Avg daily volume
- 155K
- Next earnings
- Aug 12 · in 26d
- Exchange
- XNAS
Why is $KLRS up today?
KLRS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on KLRS today, peaking at 5.0x its normal volume. Fresh from the SEC: Kalaris Therapeutics, Inc. filed an 8-K: Regulation FD Disclosure, Other Material Event. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying2 open-market buys2 buys, 1 sells last 3 months (4/2 over 12 months)Show 7 recent transactionsMinimize 7 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Akkaraju Srinivas Director | Bought (open market) | +244K 1.0% of company | added 12% | 2.22M | $1.2M at $4.83 | May 20, 26 |
Akkaraju Srinivas Director | Sold (automatic/other) | -67K 0.3% of company | sold 0.6% | 10.66M | n/a | May 20, 26 |
Akkaraju Srinivas Director | Acquired (grant/award) | +19K 0.08% of company | added 0.2% | 12.92M | n/a | May 20, 26 |
Hagen Brett R Officer | Sold (automatic/other) | -2K | n/a | n/a | $13K at $6.72 | Mar 20, 26 |
Akkaraju Srinivas Director | Acquired (grant/award) | +1.50M 6.3% of company | added 13% | 12.95M | $15.0M at $10.00 | Dec 22, 25 |
Akkaraju Srinivas Director | Bought (open market) | +480K 2.0% of company | added 3.8% | 12.95M | $5.0M at $10.42 | Dec 18, 25 |
Hagen Brett R Officer | Sold (automatic/other) | -907 | sold 32% | 2K | $8K at $8.97 | Mar 26, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $KLRS runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- At-the-market (ATM) program — sells new shares into the market gradually over time · About $100M in size
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$KLRS Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$KLRS Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Get free $KLRS alerts the moment volume spikes
Our scanner flagged $KLRS 4 times in the last 30 days. Create a free account to track $KLRS, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
KLRS stock FAQ
Why is $KLRS up today?
KLRS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on KLRS today, peaking at 5.0x its normal volume. Fresh from the SEC: Kalaris Therapeutics, Inc. filed an 8-K: Regulation FD Disclosure, Other Material Event. A material company disclosure like this is often the real catalyst behind a move of this size.
What is the KLRS stock price today?
KLRS last traded at $5.37, up 16.49% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live KLRS alerts?
The KLRS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged KLRS 4 times in the last 30 days.
What exchange is KLRS on?
KLRS (Kalaris Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $110M.
Is KLRS good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge KLRS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.